125 results about "NEEDLE/SYRINGE" patented technology

A radio frequency identification (RFID) system for use with active implantable medical devices (AIMD) implanted in a patient comprises an interrogator and an RFID tag comprising a substrate, an RFID chip, and an antenna. The RFID is typically enclosed in a biocompatible and hermetically sealed container comprising a ceramic housing, an end cap and an encapsulant. The RFID tag or sealed container may be affixed to an AIMD or surgically implanted in a patient adjacent to an AIMD. Alternatively, the sealed container may be injected into body tissue by a large needle syringe. The RFID tag may store information about an AIMD including manufacturer, model number and serial number. The RFID tag may also store information about a treating physician and / or patient including the treating physician's name and contact information, the patient's name, contact information, medical condition, treatment and other relevant information.

A syringe assembly including an adapter, a sheath and filling spike for connecting to said adapter and an intravenous connector for intravenously administering medicine to a patient. The barrel may be connected to the adapter and the filling spike for filling the barrel with medicine. The medicine can then be injected into a patient through either the needleless intravenous injection system or through a retractable needle assembly.

In an aspect, a medication delivering injector which includes a housing having opposing proximal and distal ends and an accessible internal cavity for inserting and removing a medicament container such as a syringe. The injector is designed to hold and manipulate a medication delivery device such as a large variety of standard and non-standard medical syringes with fixed or attached needles, assembled such that centrally located is a cylinder containing a liquid medicament and attached either permanently or removably to the distal end of the cylinder, is a hypodermic needle or cannula in fluidic communication with the cylinder. The needle can be from one-half inches to one-and-one-half inches in length in the illustrated embodiment and other sizes are possible by changes in scale of the injector. At the proximal end of the cylinder is an opening with an inserted seal or bung with an attached rod thus constituting a plunger. The central medicament containing cylinder could also be a standard medicament cartridge. Hereinafter, both are referred to as a “syringe”. A lid or access cover which, in an open position permits insertion and removal of the syringe into / from the housing in a horizontal fashion thus providing ease of loading. The syringe is inserted with the needle end toward the distal end of the housing and the plunger toward the proximal end of the housing. A movable carriage is disposed in the proximal end of the housing and slides in the axial direction forwards and rearwards such that a syringe, whose proximal end is gripped by the carriage, so moves with the carriage such that the needle exits the housing at the distal end of the housing and pierces the tissue of the patient prior to dispensing of the medicament, and then is retracted after the medicament has been dispensed by retraction of the carriage. Attached to the carriage is an actuator which pushes on the syringe plunger causing the medicament contained within the syringe cylinder to be dispensed through the needle into the patient's tissue. In one embodiment suitable for both removable needle and fixed needle syringes, the proximal end of the syringe including the syringe finger flange is gripped by an elastomeric flange grip which resides within the carriage, while the syringe distal end resides in and is supported by a “syringe guide” which is attached to the carriage and thus moved with it. In another embodiment which is so made to accommodate syringes with removable needles and their safe disposal, the syringe flange at the proximal end of the cylinder is gripped by an elastomeric flange grip which resides in the carriage as described above, while the syringe distal end is supported by a needle which resides in a removable disposable needle shield. The needle guide is biased toward the carriage and thus, the syringe body is compressed and guided as the carriage moves forward and rearward.Both the movement of the carriage and the actuator are controlled by servo motors which are controlled by electronics and a microcontroller so operating such that speeds and accelerations are controlled smoothly and gently so as to avoid the stop / start motion of motors controlled by limit switches and simple electronics or the vibration and abruptness such as result from injectors powered by compressed springs or gas. Furthermore, the forces are adaptive to the loads imposed and the requirements necessary for the proper dispensation of medicaments with high viscosity or sensitivity to shear forces.The housing, approximately midway between proximal and distal ends, is affixed by a hinge such that the device can be folded in half to provide for a more compact device to be stored and transported.On the distal end of the housing are electrical sensor pads in communication with the microcontroller such that contact with the patient's skin and the angle at which the injector is held against the skin and the steadiness with which the injector is being held can be ascertained. Within the housing are a haptic vibrator and an audio speaker, both producing a vibration which is variable in pitch in such a manner that biofeedback is provided to the injector user as to the pressure, angle and steadiness with which they are holding the injector against the skin. This facilitates the action of injection oneself in the gluteus muscle where visual feedback isn't available to the patient.Multiplexed onto the electrical sensor pads, is a TENS (Transcutaneous Electrical Nerve Stimulation) generator which is operational (at the user's choice) just before and during the injection to interrupt or quench the pain of tissue perforation often accompanied with needle injections.Contained on the surface of the housing such as on the access cover, is a display such that user menus, device state, directions, and battery charge status, etc. are displayed. Also contained on the surface of the housing, on the proximal half, are buttons which control the menus and selections that are shown on the display. These selections provide for the user to set such parameters as hypodermic insertion speed and medicament dispensing speeds, the preferred mode of user biofeedback which can include: speech mode (which can be accompanied by musical themes and ringtones, plus variable pitch tone and haptic vibration), MP3 mode (which has speech muted but includes musical ringtones and variable pitch tone and haptic vibration), and haptic mode (which is haptic vibration and audio tone queues needed for injector position biofeedback and readiness), plus mute mode (which provides no audio but the haptic vibration remains), and none, which provides no vibrational biofeedback, yet the display information always remains available.Also contained on the surface of the housing on the distal half, is an “injection initiate” button which causes the sequences required for performance of an injection to occur if said button is “enabled”.Contained within the electronics and its operating program is the ability to audibly play pre-recorded human speech in any language such that: directions in the form of consecutive steps which are required to load the medicament container (syringe) into the device, consecutive steps to perform an injection, steps to remove and properly dispose of parts, to alert of device status and menu choices, etc. can be played through the audio speaker. Also contained within the electronics and program is the ability to play musical ringtones as a distraction during the needle insertion and injection or when a scheduled injection alarm is reached, or calming human voice exhibiting bedside manner during the needle insertion and injection.Also contained within the electronics and software is a real-time clock-calendar which can store a patient's injection schedule and play a musical ringtone as an alarm as each scheduled injection becomes due. Also contained within the electronics and software are the ability to communicate with a personal computer through a USB port, which can also charge the injector's rechargeable battery. The battery in one embodiment, consists of three AAA batteries which can be rechargeable or non-rechargeable. The USB port in combination with an application running on the personal computer, is used to download the injection schedule into the real-time clock-calendar and to download ringtones and musical themes of the user's choice and to download foreign language sets for the pre-recorded human language feature.The injector can be further equipped with the capability to aspirate the tissue by drawing back on the plunger thus creating a vacuum into which fluids will flow. These fluids enter the syringe cylinder where they can be checked for the presence of blood by optical absorption in the red spectrum. This information is useful in the instances where intramuscular injections are to be given with drugs whose ‘Full Prescribing Information’ instructs the patient to aspirate and check for blood in the syringe which indicates that the puncture of a vein has occurred, and if so detected, to abort the injection and then re-inject into a different location.

An apparatus provides automatically controlled facial rejuvenation treatments and is comprised of a scanner for scanning a patient's face, a treatment robot, including a plurality of dermatological devices for treatment of facial skin, and a computer coupled to the scanner and robot for determining a treatment protocol of the patient's face based on a scanned input of the patient's face and for generating a plurality of commands for the treatment robot for movement and / or control of the plurality of dermatological devices for the automated treatment of the skin of the patient's face. A dermatological laser, needle injector, and / or air injector are used. The needle injector injects a minute amount of substance at a multiplicity of points within a computer-identified treatment area on the patient's face.

Featured is a robot and a needle delivery apparatus. Such a robot comprises a plurality of actuators coupled to control locating any of number of intervention specific medical devices such as intervention specific needle injectors. Such a robot is usable with image guided interventions using any of a number of types of medical imaging devices or apparatuses including MRI. The end-effector can include an automated low needle delivery apparatus that is configured for dose radiation seed brachytherapy injection. Also featured is an automated seed magazine for delivering seeds to such an needle delivery apparatus adapted for brachytherapy seed injection.

The invention relates to a method for minimizing mean blood glucose levels in an insulin dependent patient by administering insulin to the patient in a sufficiently fast manner to provide a difference of 50% or less between high and low blood glucose levels. Advantageously, the insulin is administered to the patient by jet injection and the high and low blood glucose levels differ by an amount that is less than that which would be obtained after injection of insulin by a conventional needle syringe. The invention also relates to a method for reducing mean blood glucose levels in an insulin dependent patient that is receiving insulin through a conventional syringe and needle arrangement. This method provides for administration of the insulin to the patient by jet injection rather than by the syringe by substituting a jet injector for the syringe.

A device having a needle injector pivotally attached to an ultrasound transceiver is operated to place a sterilizable needle or needle / cannula unit within a blood vessel by a single user-device operator in which the blood vessel is made visible in a monitor image by ultrasound insonification. A guidance template is overlapped on at least one of a transverse, longitudinal, or three-dimensionally imaged blood vessel that illustrates a predicted path of the needle when it undergoes movement implemented by a controller. In alternate embodiments the needle injector, ultrasound transceiver, and needle or needle / cannula unit may be contained within a flexible sheath that is capable of being sterilized.

A fixed needle syringe having a medicine compartment, a hypodermic needle, a piston, and a plunger is provided. The hypodermic needle is in fluid communication with the medicine compartment. The piston is slideably disposed in the medicine compartment. The plunger is secured to the piston. The plunger has a bore defined therethrough, where the bore allows access to the piston through the plunger.

A syringe and detachable needle assembly having reduced dead space features includes an elongate syringe barrel having open distal end including a collar and a distally facing annular surface projecting inwardly from the collar. A needle assembly includes a hub having a proximally facing annular surface and an outwardly projecting annular sealing ring positioned distally from the surface. The needle assembly also includes a cannula having a lumen therethrough connected to the distal end of the hub. Structure is provided for engaging the hub to the barrel resulting in the annular surface of the barrel contacting the annular surface of the hub to form a primary seal between said barrel and said hub and the annular sealing ring contacting the collar to form a secondary seal between the barrel and the hub.

A method and apparatus for administering a pharmaceutical. The method employs a delivery device including a housing, a pharmaceutical containing needled syringe movable within the housing, an activation button disposed at one of the housing, and wherein the housing is flared radially outward at the other end and designed to allow visibility of the needled syringe. A skin-contacting surface of the housing at the flared end is designed to limit slippage along the skin, and at least one injection targeting guide is provided. When the device is sited for injection, and without pressing the delivery device housing toward the injection site with any predetermined force by the one hand holding the housing, the activation button may be plunged with the other hand toward the housing to trigger an advancing assembly within the device that first automatically advances the needled syringe to insert a needle into the injection site, and that second automatically advances the syringe piston to force pharmaceutical through the inserted needle.

An apparatus provides automatically controlled facial rejuvenation treatments and is comprised of a scanner for scanning a patient's face, a treatment robot, including a plurality of dermatological devices for treatment of facial skin, and a computer coupled to the scanner and robot for determining a treatment protocol of the patient's face based on a scanned input of the patient's face and for generating a plurality of commands for the treatment robot for movement and / or control of the plurality of dermatological devices for the automated treatment of the skin of the patient's face. A dermatological laser, needle injector, and / or air injector are used. The needle injector injects a minute amount of substance at a multiplicity of points within a computer-identified treatment area on the patient's face.

Embodiments of a retractable syringe assembly are provided that include a dual syringe barrel configuration. In one or more embodiments, the assemblies include a fluid barrel for retaining fluid and a retraction barrel for housing the retraction feature and the needle hub assembly. The assemblies include a trigger element that moves with the plunger rod to activate the retraction feature within the retraction mechanism.

To enable a user to readily determine the gauge of the needle of a needle assembly that has a base and a needle protective housing pivotably attached thereto, the needle assembly is injection molded from a color coded molding material which color was preassigned to correspond to the gauge of the needle. As a result, both the base and the protective housing of the needle assembly have the same specific color, and reflect or provide and indication of the given gauge of the needle. The needle sheath that covers the needle prior to use may be made of a plastics material that may be clear, or have the same or a different color than that of the needle assembly. The gauge of the needle of a fixed needle syringe could also be ascertained by its color coded needle protective housing. Color coded markings that correspond to the gauge of the needle may also be printed onto the syringe barrel of the fixed needle syringe.

A safety shield system for a needle cannula of a pen needle injector or similar device, wherein the safety shield may be retracted from a first position enclosing the needle to a second position exposing the needle for injection. The safety shield system permits retraction of the safety shield during use, but extends the shield enclosing the needle in a locked position following use. The shield system is utilized with a pen needle injector having a double ended needle cannula mounted in a hub received on the open end of the pen needle injector. The assembly is disposed of by removing the assembly and needle cannula hub and storing the assembly in the cup-shaped cap enclosing the exposed end of the needle cannula within the cap. The cap includes internal radial ribs preventing retraction of the shield prior to removing the cap preventing inadvertently piercing the cap during assembly.

A cartridge for use with a blood vessel access system and device. The cartridge includes a slideable needle mount and a slideable cannula mount, the slideable needle mount having a needle in slideable connection with a lumen of a cannula held by the needle mount. The slideable needle mount and the slideable cannula mount are removeably attachable with separate moveable platforms of a needle injector that is pivotally attached to a handheld ultrasound transceiver in signal communication with a computer processing unit connected with a monitor. Upon insonification of a patient's vasculature using the handheld ultrasound transceiver pressed against the surface of the patient, needle injection and subsequent cannulation of a targeted blood vessel appearing on the monitor is accomplished by deploying the needle and cannula from the cartridge via motorization of the moveable platforms that is initiated by the user operating a controller on the device's needle injector.

A cutting element for a retracting needle syringe having a plunger with a cuttable distal end and a spring biased needle held by a cuttable support and a cutting element capable of cutting the cuttable distal end and the cuttable support includes a body portion having a proximal end, a distal end side wall therebetween and a passageway therethrough. The distal end of the body portion includes a cutting edge and a raised distally projecting tapered cutting tooth having distally converging edges. At least one tooth edge includes a sharp side wall for cutting the distal end of the plunger and the needle support.

A device for carrying out solid phase microextraction is a fiber contained in a syringe. The fiber can be solid or hollow. The syringe has a barrel and a plunger slidable within the barrel, the plunger having a handle extending from one end of the barrel. A hollow needle extends from an end of the barrel opposite to the plunger. The fiber is contained in the needle. When the plunger is depressed, the fiber extends beyond a free end of the needle and when the plunger is in a withdrawn position, the fiber is located within the needle. The syringe protects the fiber from damage. When it is desired to analyze a sample in a bottle having a septum, the needle is inserted through the septum and the plunger is depressed so that the fiber will extend into the sample. After one or two minutes, the plunger is moved to the withdrawn position so that the fiber will return to the needle and the syringe is withdrawn from the sample bottle. The syringe is then inserted through a septum in a gas injection port of a gas chromatograph. The plunger is again depressed so that the fiber will extend into the gas chromatograph and an analysis of the components on the fiber is carried out. Then, the plunger is moved to the withdrawn and the syringe is withdrawn from the injection port. Previously, samples were analyzed using liquid-liquid extraction or using cartridges. Both of these methods are relatively expensive and time consuming. Both of these methods also require the use of solvents which can be difficult and expensive to dispose of.

A biological and micro-capsule technology to improve slow-release capability of micro-capsule which includes the following steps: add a strain of microorganism liquid seed into sodium alginate solution ,add the above solution into glutin-CaCl2 intermixture with certain pH value in 40-45DEG C temperature and 40-60 drops / min velocity, stabilize for3.5-5h to form micro-capsule rudiment, add CaCl2 solution to re-calcify for 10-15min, add chitosan solution with certain pH value for 2-3h for re-coacervation, immerse in steriled saline solution for 6-24h for proliferating. Micro-capsule made by this method shows uniform shape, well fastness and excellent slow-release capability.

The invention provides a method for isolating and culturing human primary hepatocytes, comprising the following steps: cleaning blood clots on surfaces of hepatic tissues by using D-Hank's solution and cutting off connective tissues; using a needle syringe for puncturing on multipoints to perfuse anterior perfusion solution preheated to 38 DEG C so that a hepatic tissue block changes from dark red to gray and the effluent anterior perfusion solution becomes clear; using the needle for puncturing on multipoints to perfuse preheated recyclable type II collagenase solution until the hepatic tissue block is loosened and inelastic and has turtleback cracks on the surface; scissoring the hepatic tissue block, passively isolating the hepatic tissues, removing residual envelops and fibrillar connective tissues and continuously shaking and digesting in the type II collagenase solution at 37 DEG C; blowing and beating digest into hepatocyte suspension, filtering the suspension under ice bath condition, collecting filtered suspension, transferring the filtered suspension to a centrifuging tube and centrifuging at low speed; adding bottom precipitate produced from the primary low-speed centrifuging of the filtered suspension to erythrocyte lysate, blowing and beating, standing at room temperature, adding Dulbecco's modified eagle medium (DMEM), mixing the mixture uniformly, cleaning, centrifuging at low speed, adding DMEM again, mixing uniformly, centrifuging at low speed for 2-4 times and adding bottom precipitate produced from the last-time low-speed centrifuging to Williams' MediumE complete medium suspension; adjusting the hepatocytes density to 1*105 / ml, inoculating the hepatocytes in a culture bottle laid with rat tropocollagen, carrying out constant culturing in a CO2 incubator at 37 DEG C, changing the suspension to remove died hepatocytes and non-adherent hepatocytes after the hepatocytes are adhered to the wall and continually culturing the hepatocytes.

A plunger for a retracting needle syringe includes a hollow elongate body portion having a proximal end, a distal end, and a side wall therebetween defining a cavity. The distal end includes a distal wall having an inside surface and an outside surface. A stopper, at the distal end of the body portion, includes a peripheral portion performing a seal with the inside surface of a syringe barrel and at least one radial element extending from about a center of the outside surface of the distal wall to the peripheral portion. The distal end of the body portion includes at least one primary chamfer in the cavity at an intersection of the inside surface of the distal wall and the side wall. The chamfer is positioned under the at least one radial element for supporting the distal wall and the radial element when a hollow sleeve in the syringe barrel cuts through the end wall plunger. A secondary, smaller chamfer on each side of the primary chamfer is also provided.

A cannula and syringe assembly includes a syringe barrel having an opening at one end thereof defined by a forward edge; a needle carrier seated within the opening and attached to the syringe barrel; and a cannula attached to the needle carrier; wherein the cannula is provided with at least one engagement surface that engages the forward edge of the opening in the syringe barrel such that forces exerted on the cannula during use are transferred to the syringe barrel.

A syringe including a barrel (14), a retractable needle (12) and a plunger rod assembly (22) including inner (30) and outer (24) members with a stopper (46) for expelling fluids from the syringe is disclosed. An activation member (40, 44) associated with the plunger rod permits relative movement of the inner and outer members when activated. The stopper is configured to compress a sufficient amount when advanced distally in the barrel to cause the activation element to engage and cause retraction of the needle within the syringe.

A neuro-vasculature access system and device for placing a cannula adjacent to a nerve. The neuro-vasculature access system and device includes a needle injector pivotally attached to an ultrasound transceiver which is operated to place a sterilizable needle or needle / cannula unit within the neuro-vasculature of a patient by a single user-device operator in which the neuro-vasculature is made visible in a monitor image by ultrasound insonification. A guidance template having an expected path trajectory is overlaid on at least one of a transverse short axis, a longitudinal long axis, or a three-dimensional image of the neuro-vasculature and predicts path of the needle or needle with overlapping cannula when it undergoes movement implemented by a controller located on the needle injector. The needle injector, ultrasound transceiver, and needle or needle / cannula unit may be contained within a flexible sheath capable of being sterilized.

The invention relates to a veterinary needleless injector comprising drug containing tube components, an injector and a high pressure air supply; the injector includes a magnetic thrust piston arranged inside a cavity on a housing; a pure iron locating part corresponding to the magnetic thrust piston is arranged in the cavity; a tail rod end protrudes out of the housing; the rod end of the magnetic thrust piston is movably connected with a piston rod of an injection piston inside an injection syringe arranged at the front end of the housing; an injection head is arranged at the front end of the injection syringe; a drug inlet port on one side is connected with the outlet port of the drug containing tube components through pipe fittings; a switch plug is arranged at one end of the inside of a through cavity at the lower part of the housing; the outer end is in contact with the side surface of a trigger; a hollow gas circuit movable switch plug corresponding to the switch plug is arranged on the other side in the cavity; and a spring is arranged at the tail end which is connected with the high pressure air supply through pipe fittings. The invention has the advantages of rapidity, high efficiency, no infliction of pain on animals, continuous injection, accurate control of dosage, controllable and adjustable injection pressure for livestock, effective prohibition against cross infection and good safety.